Vasomotor Symptoms Market Size, Share, Trends, Opportunities, Growth Analysis and Forecast to 2032
Vasomotor
Symptoms Market Size was valued at USD 3.5 billion in 2022. The vasomotor symptoms
market industry is projected to grow from USD 3.74 Billion in 2023 to USD 5.58
billion by 2030
The
global vasomotor symptoms market is driven by several factors, such as
rising older female population, rising initiatives by public and private organizations
to create awareness regarding vasomotor symptoms management options, increasing
product launches, and a number of clinical trials by the prominent players in
the market. The increasing menopausal women also contribute heavily to the
growth of this market. By 2030, the world population of menopausal and
postmenopausal women is projected to increase to 1.2 billion, with 47 million
new entrants each year.
Major Key
Players:
The prolific contenders in the Key Market
Players are Allergan (Ireland), Pfizer Inc. (US), Eli Lily and
Company (US), Novartis AG (Switzerland), Emcure Pharmaceuticals Ltd (India),
Merck & Co., Inc. (US), TherapeuticsMD, Inc. (US), Mithra Pharmaceuticals
(Belgium), Novo Nordisk A/S (Denmark), Procter & Gamble (US), EndoCeutics,
Inc. (Canada), Amag Pharmaceuticals (US), and Teva Pharmaceuticals (Israel).
Segment Analysis
Global Vasomotor Symptoms Market has been segmented
based on the Therapy Type and Distribution Channel.
The market, based on therapy type, has been segmented
into hormonal and non-hormonal. The market, based on hormonal therapy, has been
further divided into estrogen, progesterone, and combination. The market, based
on hormonal therapy, held a major share in 2019 owing to the widespread use and
high preference rate. The market, based on non-hormonal therapy, has been
further divided into antidepressants and others.
The global vasomotor symptoms market has been
segmented, based on distribution channel, into hospital pharmacies, online
stores, and retail pharmacies. The hospital pharmacies segment held the
majority share of the market in 2019 owing to the increasing number of in-visit
patient admissions, whereas the online stores segment is projected to be the
fastest-growing segment during the study period owing to the increasing
preference of this distribution channels owing to the widespread availability
and rise in awareness regarding the e-commerce channels.
Regional Analysis
The market has been divided, by
region, into the Americas, Europe, Asia-Pacific, and the Middle East &
Africa. The Americas held the maximum share in 2019, owing to the rise in
menopausal women in the US. For instance, in the US, approximately 1.3 million
women become menopausal each year. The vasomotor symptoms market in the
Americas has further been branched into North America and Latin America, with
the North American market divided into the US and Canada. The European
vasomotor symptoms market has been categorized as Western Europe and Eastern
Europe. The Western European market has further been classified as Germany,
France, the UK, Italy, Spain, and the rest of Western Europe. The European
market for vasomotor symptoms is expected to hold a substantial share owing to
the increase in the number of clinical trials by the prominent players. The
vasomotor symptoms market in Asia-Pacific has been segmented into Japan, China,
India, South Korea, Australia, and the rest of Asia-Pacific. The vasomotor
symptoms market in this region is anticipated to be the fastest-growing during
the forecast period due to the increasing uptake and adoption rate of hormonal
therapy. Increasing patient pool also fuels the market growth. The vasomotor
symptoms market in the Middle East & Africa has been divided into the
Middle East and Africa.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Comments
Post a Comment